Therapeutic effect of organoselenium dietary supplementation in a sporadic dementia of Alzheimer's type model in rats

Journal of Nutritional Biochemistry

Volumn 24, Issue 1, 2013, Pages 311-317

  Pinton, Simone ^a   Brüning, César A ^a   Sartori Oliveira, Carla E ^a   Prigol, Marina ^a   Nogueira, Cristina Wayne ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Alzheimer's disease animal model; Energy metabolism; Nitration; Oxidative stress; Selenium

Indexed keywords

ACETYLCHOLINESTERASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; GLUCOSE; ORGANOSELENIUM DERIVATIVE; P,P' METHOXYLDIPHENYL DISELENIDE; STREPTOZOCIN; THIOL; TYROSINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN CORTEX; BRAIN METABOLISM; COGNITION; DIET SUPPLEMENTATION; ENERGY METABOLISM; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HIPPOCAMPUS; LEARNING; LONG TERM MEMORY; MALE; MAZE TEST; MEMORY DISORDER; NITRATION; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; RAT; TASK PERFORMANCE; THERAPY EFFECT;

ACETYLCHOLINESTERASE; ALZHEIMER DISEASE; ANIMALS; AVOIDANCE LEARNING; BENZENE DERIVATIVES; BRAIN; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; MALE; MAZE LEARNING; NEUROPROTECTIVE AGENTS; ORGANOSELENIUM COMPOUNDS; OXIDATIVE STRESS; RATS; RATS, WISTAR; STREPTOZOCIN; TYROSINE;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 84870396204     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.06.012     Document Type: Article

References (50)

1. Stix G. Alzheimer's: forestalling the darkness. Sci Am 2010, 302:50-57.
2. Global burden of neurological disorders: estimates and projections 2006, 281-304. [Switzerland].
3. Xu J.-H., Hu H.-T., Liu Y., Qian Y.-H., Liu Z.-H., Tan Q.-R., et al. Neuroprotective effects of ebselen are associated with the regulation of Bcl-2 and Bax proteins in cultured mouse cortical neurons. Neurosci Lett 2006, 399:210-214.
4. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
5. Allmang C., Wurth L., Krol A. The selenium to selenoprotein pathway in eukaryotes: more molecular partners than anticipated. Biochim Biophys Acta 2009, 1790:1415-1423.
6. Loef M., Schrauzer G.N., Walach H. Selenium and Alzheimer's disease: a systematic review. J Alzheimers Dis 2011, 26:81-104.
7. Cornelli U. Treatment of Alzheimer's disease with a cholinesterase inhibitor combined with antioxidants. Neurodegener Dis 2010, 7:193-202.
8. Van Rhijn A.G., Prior C.A., Corrigan F.M. Dietary supplementation with zinc sulphate, sodium selenite and fatty acids in early dementia of Alzheimer's type. J Nutr Med 1990, 1:259-266.
9. Vural H., Demirin H., Kara Y., Eren I., Delibas N. Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer's disease. J Trace Elem Med Biol 2010, 23:169-173.
10. Akbaraly T.N., Hininger-Favier I., Carrière I., Arnaud J., Gourlet V., Roussel A.M., et al. Plasma selenium over time and cognitive decline in the elderly. Epidemiology 2007, 18:52-58.
11. Gwon A.R., Park J.S., Park J.H., Baik S.H., Jeong H.Y., Hyun D.H., et al. Selenium attenuates Aβ production and Aβ-induced neuronal death. Neurosci Lett 2010, 469:391-395.
12. Ishrat T., Parveen K., Khan M.M., Khuwaja G., Khan M.B., Yousu S., et al. Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's disease. Brain Res 2009, 1281:117-127.
13. Souza A.C., Brüning C.A., Leite M.R., Zeni G., Nogueira C.W. Diphenyl diselenide improves scopolamine-induced memory impairment in mice. Behav Pharmacol 2010, 21:556-562.
14. Mahan D.C. Effect of organic and inorganic selenium sources and levels on sow colostrum and milk selenium content. J Anim Sci 2000, 78:100-105.
15. Lovell M.A., Xiong S., Lyubartseva G., Markesbery W.R. Organoselenium (Sel-Plex diet) decreases amyloid burden and RNA and DNA oxidative damage in APP/PS1 mice. Free Radic Biol Med 2009, 46:1527-1533.
16. Nogueira C.W., Rocha J.B.T. Diphenyl diselenide: a Janus-faced molecule. J Br Chem Soc 2010, 21:2055-2071.
17. Rosa R.M., Flores D.G., Appelt H.R., Braga A.L., Henriques J.A.P., Roesler R. Facilitation of long-term object recognition memory by pretraining administration of diphenyl diselenide in mice. Neurosci Lett 2003, 341:217-220.
18. Stangherlin E.C., Luchese C., Pinton S., Rocha J.B., Nogueira C.W. Sub-chronical exposure to diphenyl diselenide enhances acquisition and retention of spatial memory in rats. Brain Res 2008, 1201:106-113.
19. Pinton S., da Rocha J.T., Gai B.M., Prigol M., da Rosa L.V., Nogueira C.W. Neuroprotector effect of p, p'-methoxyl-diphenyl diselenide in a model of sporadic dementia of Alzheimer's type in mice: contribution of antioxidant mechanism. Cell Biochem Funct 2011, 29:235-243.
20. Pinton S., da Rocha J.T., Zeni G., Nogueira C.W. Organoselenium improves memory decline in mice: involvement of acetylcholinesterase activity. Neurosci Lett 2010, 472:56-60.
21. Lannert H., Hoyer S. Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci 1998, 112:1199-1208.
22. Agrawal R., Tyagi E., Shukla R., Nath C. A study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementia. Neuropharmacology 2009, 56:779-787.
23. Javed H., Khan M.M., Khan A., Vaibhav K., Ahmad A., Khuwaja G., et al. S-allyl cysteine attenuates oxidative stress associated cognitive impairment and neurodegeneration in mouse model of streptozotocin-induced experimental dementia of Alzheimer's type. Brain Res 2011, 1389:133-142.
24. Paulmier C. Selenium reagents and intermediates 1986, Organic synthesis, Pergamon, Oxford.
25. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1986, Academic Press, San Diego.
26. de Bem A.F., Portella R.F., Colpo E., Duarte M.M.M.F., Frediane A., Taube P.S., et al. Diphenyl diselenide decreases serum levels of total cholesterol and tissue oxidative stress in cholesterol-fed rabbits. Basic Clin Pharmacol Toxicol 2009, 105:17-23.
27. Sakaguchi M., Koseki M., Wakamatsu M., Matsumura E. Effects of systemic administration of casomorphin-5 on learning and memory in mice. Eur J Pharmacol 2006, 530:81-87.
28. Morris R. Developments of a water-maze procedure for studying spatial-learning in the rat. J Neurosci Methods 1984, 11:47-60.
29. Walsh R.N., Cummins R.A. The open-field test: a critical review. Psychol Bull 1976, 83:482-504.
30. Loetchutinat C., Kothan S., Dechsupa S., Meesungnoen J., Jay-Gerin J., Mankhetkorn S. Spectrofluorometric determination of intracellular levels of reactive oxygen species in drug-sensitive and drug-resistant cancer cells using the 2',7'-dichlorofluorescein diacetate assay. Radiat Phys Chem 2005, 72:323-331.
31. Ellman G.L. Tissue sulfhydryl groups. Arch Biochem 1959, 82:0-77.
32. Erdal N., Gürgül S., Tamer L., Ayaz L. Effects of long-term exposure of extremely low frequency magnetic field on oxidative/nitrosative stress in rat liver. J Radiat Res 2008, 49:181-187.
33. Özogul F., Taylor A.K.D., Quantick P., Özogul Y. A rapid HPLC-determination of ATP-releated compounds and its applications to herring stored under modified atmosphere. Int J Food Sci Technol 2000, 35:549-554.
34. Ellman G.L., Courtney D.K., Andres V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961, 7:88-95.
35. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal Biochem 1976, 72:248-254.
36. Sharma N., Deshmukh R., Bedi K.L. SP600125, a competitive inhibitor of JNK attenuates streptozotocin induced neurocognitive deficit and oxidative stress in rats. Pharmacol Biochem Behav 2010, 96:386-394.
37. Mancuso M., Calsolaro V., Orsucci D., Carlesi C., Choub A., Piazza S., et al. Mitochondria, cognitive impairment, and Alzheimer's disease. Int J Alzheimers Dis 2009, 2009:1-8.
38. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 1997, 23:134-147.
39. Dringen R. Metabolism and functions of glutathione in brain. Prog Neurobiol 2000, 62:649-671.
40. Luchese C., Nogueira C.W. Diphenyl diselenide in its selenol form has dehydroascorbate reductase and glutathione S-transferase-like activity dependent on the glutathione content. J Pharm Pharmacol 2010, 62:1146-1151.
41. Freitas A.S., Prestes A.S., Wagner C., Sudati J.H., Alves D., Porciúncula L.O., et al. Reduction of diphenyl diselenide and analogs by mammalian thioredoxin reductase is independent of their glutathione peroxidase-like activity: a possible novel pathway for their antioxidant activity. Molecules 2010, 15:7699-7714.
42. Tohgi H., Abe T., Yamazaki K., Murata T., Ishizaki E., Isobe C. Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease. Neurosci Lett 1999, 269:52-54.
43. Horiguchi T., Uryu K., Giasson B.I., Ischiropoulos H., LightFoot R., Bellmann C., et al. Nitration of tau protein is linked to neurodegeneration in tauopathie. Am J Pathol 2003, 163:1021-1031.
44. Zhang Y.J., Xu Y.F., Liu Y.H., Yin J., Wang J.Z. Nitric oxide induces tau hyperphosphorylation via glycogen synthase kinase-3b. FEBS Lett 2005, 579:6230-6236.
45. Zhang Y.-J., Xu Y.-F., Liu Y.-H., Yin J., Li H.-L., Wang Q., et al. Peroxynitrite induces Alzheimer-like tau modifications and accumulation in rat brain and its underlying mechanisms. FASEB J 2006, 20:1431-1442.
46. Jesse C.R., Wilhelm E.A., Bortolatto C.F., Rocha J.B., Nogueira C.W. Involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of bis selenide in the mouse tail suspension test. Eur J Pharmacol 2010, 635:135-141.
47. Porciúncula L.O., Rocha J.B.T., Cimarosti H., Vinadé L., Ghisleni G., Salbego, et al. Neuroprotective effect of ebselen on rat hippocampal slices submitted to oxygen-glucose deprivation: correlation with immunocontent of inducible nitric oxide synthase. Neurosci Lett 2003, 346:101-104.
48. Grunblatt E., Salkovic-Petrisic M., Osmanovic J., Riederer P., Hoyer S. Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein. J Neurochem 2007, 101:757-770.
49. Duelli R., Schröck H., Kuschinsky W., Hoyer S. Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. Int J Dev Neurosci 1994, 12:737-743.
50. Lester-coll N., Rivera E.J., Soscia S.J., Doiron K., Wands J.R., de la Monte S.M.J. Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's diseases. J Alzheimers Dis 2006, 9:13-33.